Broad Center for Stem Cell Research and Jonsson Comprehensive Cancer Center
TheChuteLab
News
< Back
John P. Chute Receives California Institute for Regenerative Medicine Leadership Award 2014
Dr. John Chute, member of UCLA’s Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and Jonsson Comprehensive Cancer Center has been awarded a Research Leadership Award of $5.1 million from the California Institute of Regenerative Medicine (CIRM), the state’s stem cell agency. Announcement of the award came at the meeting of the CIRM Independent Citizens’ Oversight Committee (ICOC), the governing board of the agency, in La Jolla, CA on May 29, 2014.
Dr. Chute is the only clinician scientist to receive a CIRM Leadership Award.
The CIRM Leadership Award is intended to bolster California’s efforts in stem cell research and further its mission to advance novel treatments and cures into medical practice. Dr. Chute’s groundbreaking research focuses on the study of hematopoietic stem cells (HSC, the cells that become blood cells) and how they grow. Specifically, he and his colleagues are defining the mechanisms through which the bone marrow microenvironment cells regulate HSC self-renewal, repair and regeneration. Among his multiple discoveries are two novel proteins that are essential to the growth of blood cells.
With this knowledge, Dr. Chute and his team can also understand how leukemia stem cells use the same mechanisms in their growth, and target those growth factors with cellular therapies.
Dr. John Chute, member of UCLA’s Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and Jonsson Comprehensive Cancer Center has been awarded a Research Leadership Award of $5.1 million from the California Institute of Regenerative Medicine (CIRM), the state’s stem cell agency. Announcement of the award came at the meeting of the CIRM Independent Citizens’ Oversight Committee (ICOC), the governing board of the agency, in La Jolla, CA on May 29, 2014.
Dr. Chute is the only clinician scientist to receive a CIRM Leadership Award.
The CIRM Leadership Award is intended to bolster California’s efforts in stem cell research and further its mission to advance novel treatments and cures into medical practice. Dr. Chute’s groundbreaking research focuses on the study of hematopoietic stem cells (HSC, the cells that become blood cells) and how they grow. Specifically, he and his colleagues are defining the mechanisms through which the bone marrow microenvironment cells regulate HSC self-renewal, repair and regeneration. Among his multiple discoveries are two novel proteins that are essential to the growth of blood cells.
With this knowledge, Dr. Chute and his team can also understand how leukemia stem cells use the same mechanisms in their growth, and target those growth factors with cellular therapies.